Cancer

The Advanced Personalized Therapeutics and Precision Surgery Program in Childhood Cancers is aiming to transform care for patients.

CHOP CVI announces new executive leadership group, and a pediatric oncologist receives funding to advance rare tumor research, in this week’s news.

Kyrie was diagnosed with a rare cancer at 6 years old. His participation in a clinical trial paved the way for a new frontline therapy.

Preclinical findings offer a potential new strategy for treating high-risk neuroblastoma.

Researchers reveal rare variants of SYNGAP1-related disorders are inherited, and a nurse scientist is featured in The Philadelphia Inquirer.

The CHOP-led trial showed that blinatumomab plus chemotherapy drastically improved survival rates for patients with B-ALL.

As the pediatric cancer charity celebrates its 20th anniversary, Cornerstone is highlighting the groundbreaking research at CHOP fueled by two decades of collaboration.

Our Faculty Spotlight, Guilherme Nader, PhD, studies how cells cope with stress in dense microenvironments, specifically in cancerous tumors.